Double-blinded, randomized phase II study using embolization with or without granulocyte-macrophage colony-stimulating factor in uveal melanoma with hepatic metastases.

Matias E. Valsecchi,Mizue Terai,David J. Eschelman,Carin F. Gonsalves,Inna Chervoneva,Jerry A. Shields,Carol L. Shields,Akira Yamamoto,Kevin L. Sullivan,M. Laudadio,David Berd,Michael J. Mastrangelo,Takami Sato

Double-blinded, randomized phase II study using embolization with or without granulocyte-macrophage colony-stimulating factor in uveal melanoma with hepatic metastases.

2015

Matias E. Valsecchi
Mizue Terai
David J. Eschelman
Carin F. Gonsalves
Inna Chervoneva
Jerry A. Shields
Carol L. Shields
Akira Yamamoto
Kevin L. Sullivan
M. Laudadio
David Berd
Michael J. Mastrangelo
Takami Sato

Purpose To investigate the effects of immunoembolization with granulocyte–macrophage colony-stimulating factor (GM-CSF) in patients with uveal melanoma (UM) with liver-only metastasis.

Keywords:

Embolization
Melanoma
Radiology
Uveal Neoplasm
Progression-free survival
Cancer research
Phases of clinical research
Bland Embolization
Metastasis
Granulocyte macrophage colony-stimulating factor
Medicine
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations